Gamma-glutamyltransferase, alanine transaminase and aspartate transaminase levels and the diagnosis of gestational diabetes mellitus

Clinical Biochemistry

Volumn 45, Issue 15, 2012, Pages 1192-1196

  Tan, Peng Chiong ^a   Aziz, Ainul Zahaniah ^a   Ismail, Ikram Shah ^a   Omar, Siti Zawiah ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Alanine transaminases; Aspartate transaminases; Gamma glutamyltransferase; Gestational diabetes; Glucose challenge test; Glucose tolerance test; Pregnancy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PREGNANCY DIABETES MELLITUS; PRENATAL DIAGNOSIS; PREVALENCE; PRIORITY JOURNAL;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; DIABETES, GESTATIONAL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; PREGNANCY; QUESTIONNAIRES; ROC CURVE; STATISTICS, NONPARAMETRIC;

EID: 84866276198     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.05.025     Document Type: Article

References (28)

1. Perry I.J., Wannamethee S.G., Shaper A.G. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 1998, 21:732-737.
2. Lee D.H., Ha M.H., Kim J.H., et al. Gamma-glutamyltransferase and diabetes-a 4 year follow-up study. Diabetologia 2003, 46:359-364.
3. Gautier A., Balkau B., Lange C., Tichet J., Bonnet F. Risk factors for incident type 2 diabetes in individuals with a BMI of <27 kg/m2: the role of gamma-glutamyltransferase. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetologia 2010, 53:247-253.
4. Lee D.H., Jacobs D.R., Gross M., et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003, 49:1358-1366.
5. Barbieux J.P., Bacq Y., Schellenberg F., Weill J., Constans T., Lamisse F. Increase of serum gamma-glutamyl transferase activity in diabetic patients is not linked to diabetes itself. Pathol Biol 1990, 38:93-98.
6. Vozarova B., Stefan N., Lindsay R.S., et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002, 51:1889-1895.
7. Sattar N., Scherbakova O., Ford I., et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes 2004, 53:2855-2860.
8. Doi Y., Kubo M., Yonemoto K., et al. Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study. Obesity (Silver Spring) 2007, 15:1841-1850.
9. Nannipieri M., Gonzales C., Baldi S., et al. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care 2005, 28:1757-1762.
10. Hanley A.J., Williams K., Festa A., et al. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2004, 53:2623-2632.
11. Tan P.C., Jacob R., Quek K.F., Omar S.Z. Pregnancy outcome in hyperemesis gravidarum and the effect of laboratory clinical indicators of hyperemesis severity. J Obstet Gynaecol Res 2007, 33:457-464.
12. Tan P.C., Mubarak S., Omar S.Z. Gamma-glutamyltransferase level in pregnancy is an independent risk factor for gestational diabetes mellitus. J Obstet Gynaecol Res 2008, 34:512-517.
13. Alanbay I., Coksuer H., Ercan M., et al. Can serum gamma-glutamyltransferase levels be useful at diagnosing gestational diabetes mellitus?. Gynecol Endocrinol 2012, 28:208-211.
14. Savvidou M., Nelson S.M., Makgoba M., Messow C.M., Sattar N., Nicolaides K. First-trimester prediction of gestational diabetes mellitus: examining the potential of combining maternal characteristics and laboratory measures. Diabetes 2010, 59:3017-3022.
15. Kim C., Newton K.M., Knopp R.H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002, 25:1862-1868.
16. Tan P.C., Ling L.P., Omar S.Z. Screening for gestational diabetes at antenatal booking in a Malaysian university hospital: the role of risk factors and threshold value for the 50-g glucose challenge test. Aust N Z J Obstet Gynaecol 2007, 47:191-197.
17. Report of a WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications 1999, Accessible on http://whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf. Last accessed Feb 19 2012.
18. Metzger B.E., Lowe L.P., Dyer A.R., et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008, 358:1991-2002.
19. Sacks D.B., Arnold M., Bakris G.L., et al. Position statement executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011, 34:1419-1423.
20. Gestational diabetes mellitus. Diabetes Care 2003, 26(Suppl. 1):S103-S105.
21. Lee D.H., Silventoinen K., Jacobs D.R., Jousilahti P., Tuomileto J. gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab 2004, 89:5410-5414.
22. Meisinger C., Lowel H., Heier M., Schneider A., Thorand B. Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population. J Intern Med 2005, 258:527-535.
23. Shlomai A., Kariv R., Leshno M., Beth-or A., Sheinberg B., Halpern Z. Large-scale population analysis reveals an extremely low threshold for "non-healthy" alanine aminotransferase that predicts diabetes mellitus. J Gastroenterol Hepatol 2010, 25:1687-1691.
24. Fraser A., Harris R., Sattar N., Ebrahim S., Davey Smith G., Lawlor D.A. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care 2009, 32:741-750.
25. Ghouri N., Preiss D., Sattar N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology 2010, 52:1156-1161.
26. Targher G. Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer - a narrative review. Clin Chem Lab Med 2010, 48:147-157.
27. Field J. Hyperemesis gravidarum: a short case study. Nurs Times 2001, 97:55.
28. Lim J.S., Lee D.H., Park J.Y., Jin S.H., Jacobs D.R. A strong interaction between serum gamma-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes: results from the Third National Health and Nutrition Examination Survey. Clin Chem 2007, 53:1092-1098.